共 22 条
[1]
Czala A.L., Manns M.P., Advances in the diagnosis, pathogenesis, and management of autoimmune hepatitis, Gastroenterology, 139, pp. 58-72, (2010)
[2]
Chapman R., Fevery J., Kalloo A., Nagorney D.M., Boberg K.M., Shneider B., Et al., Diagnosis and management of primary sclerosing cholangitis, Hepatology, 51, pp. 660-678, (2010)
[3]
Kaya M., Angulo P., Lindor K.D., Overlap of autoimmune hepatitis and primary sclerosing cholangitis: An evaluation of a modified scoring system, J Hepatol, 33, pp. 537-542, (2000)
[4]
Floreani A., Rizzotto E.R., Ferrara F., Carderi I., Caroli D., Blasone L., Et al., Clinical course and outcome of autoimmune hepatitis/primary sclerosing cholangitis overlap syndrome, Am J Gastroenterol, 100, pp. 1516-1522, (2005)
[5]
Luth S., Kanzler S., Frenzel C., Kasper H.U., Dienes H.P., Schramm C., Et al., Characteristics and long-term prognosis of the autoimmune hepatitis/primary sclerosing cholangitis overlap syndrome, J Clin Gastroenterol, 43, pp. 75-80, (2009)
[6]
Bruix J., Sherman M., AASLD practice guideline, Management of Hepatocellular Carcinoma: An Update. Hepatology, 3, pp. 1020-1022, (2011)
[7]
Yeoman A.D., Al-Chalabi T., Karani J.B., Quaglia A., Devlin J., Mieli-Vergani G., Et al., Evaluation of risk factors in the development of hepatocellular carcinoma in autoimmune hepatitis: Implications for follow-up and screening, Hepatology, 48, pp. 863-870, (2008)
[8]
Wong R.J., Gish R., Frederick T., Bzoweji N., Frenette C., Development of hepatocellular carcinoma in autoimmune hepatitis patients: A case series, Dig Dis Sci, 56, pp. 578-585, (2011)
[9]
Hennes E.M., Zeniya M., Czaja A.J., Pares A., Dalekos G.N., Krawitt E.J., Et al., Simplified criteria for the diagnosis of autoimmune hepatitis, Hepatology, 48, pp. 169-176, (2008)
[10]
Gregorio G.V., Portmann B., Karani J., Harrison P., Donaldson P.T., Vergani D., Et al., Autoimmune hepatitis/sclerosing overlap syndrome in childhood: A 16-year prospective study, Hepatology, 33, pp. 544-553, (2001)